Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Other Non Operating Income: 2017-2024

Historic Other Non Operating Income for Sunshine Biopharma (SBFM) over the last 8 years, with Dec 2024 value amounting to -$44,082.

  • Sunshine Biopharma's Other Non Operating Income fell 98.33% to $253 in Q3 2025 from the same period last year, while for Sep 2025 it was -$337,359, marking a year-over-year decrease of 214.02%. This contributed to the annual value of -$44,082 for FY2024, which is 17892.65% down from last year.
  • Sunshine Biopharma's Other Non Operating Income amounted to -$44,082 in FY2024, which was down 17,892.65% from -$245 recorded in FY2023.
  • Sunshine Biopharma's 5-year Other Non Operating Income high stood at $51,031 for FY2021, and its period low was -$44,082 during FY2024.
  • In the last 3 years, Sunshine Biopharma's Other Non Operating Income had a median value of -$245 in 2023 and averaged -$11,158.
  • In the last 5 years, Sunshine Biopharma's Other Non Operating Income soared by 564.99% in 2021 and then crashed by 17,892.65% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Other Non Operating Income (Yearly) stood at $7,674 in 2020, then soared by 564.99% to $51,031 in 2021, then plummeted by 78.73% to $10,852 in 2022, then tumbled by 102.26% to -$245 in 2023, then plummeted by 17,892.65% to -$44,082 in 2024.